Tekla Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Tekla Capital Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.42M	Hold
2023 Q1	$1.26M	Buy
2022 Q4	$839K	Buy